Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man
The release of cytoplasmic heart fatty acid-binding protein (H-FABP) into the plasma of cardiac patients up to 38 hr after the onset of the first clinical symptoms of acute myocardial infarction (AMI) was studied, using a sensitive direct and noncompetitive Enzyme Linked Immunosorbent Assay of the antigen capture type (sandwich ELISA), newly developed for the measurement of small amounts of human H-FABP in plasma samples. Plasma levels of H-FABP were compared with plasma activity levels of the myocardial cytoplasmic enzymes creatine kinase MB (CK-MB) and alpha-hydroxybutyrate dehydrogenase (α-HBDH). Upper normal levels of H-FABP (19μg/l), CK-MB (10 U/1) and α-HBDH (160 U/l) as determined in plasma from 72 blood donors served as threshold levels. H-FABP levels were significantly elevated above their threshold level within 3 hr after AMI. Peak levels of H-FABP, CK-MB and α-HBDH were reached 4.1 ± 0.9 hr, 8.4 ± 1.4 hr and 25.0 ± 9.5 hr (means ± S.D., n= 10) after acute myocardial infarction, respectively. Serial time curves of the plasma contents of H-FABP reveal that after myocardial infarction H-FABP is released in substantial amounts from human hearts. In 18 out of 22 patients with established AMI the plasma FABP level was at or above the threshold level in blood-samples taken within 3.5 hr after the first onset of symptoms of AMI, while for CK-MB this applied to 9 patients and for α-HBDH to 6 patients. These findings suggest that for an early indication of acute myocardial infarction in man cytoplasmic heart fatty acid-binding protein is more suitable than heart type creatine kinase MB and/or alpha-hydroxybutyrate dehydrogenase. (Mol Cell Biochem 116: 155–162, 1992)
Key wordsfatty acid-binding protein ELISA acute myocardial infarction
Unable to display preview. Download preview PDF.
- 8.Ingelfinger JA, Mosteller F, Thibodeau LA, Ware JH. In: Bio-statistics in clinical medicine. MacMillan Publishing Co., Inc., New York, 1983, pp 85–113Google Scholar
- 11.Wilson MB, Nakane PK. In: W Knapp, K. Holubar, G Wick (eds) Immunofluorescence and Related Techniques. Elsevier/North-Holland, Amsterdam, 1978, pp 215–224Google Scholar
- 15.Waldman TA, Strauber W, Mogielnicki RP: The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with proteinuria, the nephrotic syndrome, or uremia. J Clin Invest 51: 2162–2174, 1972Google Scholar
- 28.Paulussen RJA, Van Moerkerk HTB, Veerkamp JH: Immunochemical quantitation of fatty acid-binding proteins. Tissue distribution of liver and heart FABP types in human and porcine tissues. Int J Biochem 22: 393–398, 1990Google Scholar